ArticleEye (London, England)2018

Response to 'The importance of immunosuppression as risk and prognostic factor for periorbital non-melanoma skin cancers'.

R C Gerring et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.